Roche Sues Mylan Over Generic Xeloda ANDA
By Julie Zeveloff · April 14, 2009, 12:00 AM EDT
Hoffmann-La Roche Inc. has sued generic-drug manufacturer Mylan Pharmaceuticals Inc. for allegedly infringing a patent for the oral chemotherapy drug Xeloda after learning of Mylan's intent to make and sell a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login